United States - English - NLM (National Library of Medicine)

bryant ranch prepack - nifedipine (unii: i9zf7l6g2l) (nifedipine - unii:i9zf7l6g2l) - nifedipine 60 mg - nifedipine extended-release tablets are indicated for the management of vasospastic angina confirmed by any of the following criteria: 1) classical pattern of angina at rest accompanied by st segment elevation, 2) angina or coronary artery spasm provoked by ergonovine, or 3) angiographically demonstrated coronary artery spasm. in those patients who have had angiography, the presence of significant fixed obstructive disease is not incompatible with the diagnosis of vasospastic angina, provided that the above criteria are satisfied. nifedipine extended-release tablets may also be used where the clinical presentation suggests a possible vasospastic component, but where vasospasm has not been confirmed, e.g., where pain has a variable threshold on exertion, or in unstable angina where electrocardiographic findings are compatible with intermittent vasospasm, or when angina is refractory to nitrates and/or adequate doses of beta blockers. - (classical effort-associated angina) (classical effort-associated angina

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - nifedipine 30 mg - prolonged-release tablet - 30 mg - nifedipine 30 mg - nifedipine

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - nifedipine 60 mg - prolonged-release tablet - 60 mg - nifedipine 60 mg - nifedipine

Canada - English - Health Canada

mylan pharmaceuticals ulc - nifedipine - tablet (extended-release) - 60mg - nifedipine 60mg - dihydropyridines

Canada - English - Health Canada

mylan pharmaceuticals ulc - nifedipine - tablet (extended-release) - 30mg - nifedipine 30mg - dihydropyridines

Canada - English - Health Canada

mylan pharmaceuticals ulc - nifedipine - tablet (extended-release) - 20mg - nifedipine 20mg - dihydropyridines

Canada - English - Health Canada

mantra pharma inc - nifedipine - tablet (extended-release) - 60mg - nifedipine 60mg - dihydropyridines

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - nifedipine (unii: i9zf7l6g2l) (nifedipine - unii:i9zf7l6g2l) - nifedipine 30 mg - adalat® cc is an extended release tablet dosage form of the calcium channel blocker nifedipine. nifedipine is 3,5-pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-dimethyl ester, c17 h18 n2 o6 , and has the structural formula: nifedipine is a yellow crystalline substance, practically insoluble in water but soluble in ethanol. it has a molecular weight of 346.3. adalat cc tablets consist of an external coat and an internal core. both contain nifedipine, the coat as a slow release formulation and the core as a fast release formulation. adalat cc tablets contain either 30, 60, or 90 mg of nifedipine for once-a-day oral administration. inert ingredients in the formulation are: hydroxypropylcellulose, lactose, corn starch, crospovidone, microcrystalline cellulose, silicon dioxide, and magnesium stearate. the inert ingredients in the film coating are: hypromellose, polyethylene glycol, ferric oxide, and titanium dioxide.

Canada - English - Health Canada

bayer inc - nifedipine; acetylsalicylic acid - tablet (delayed-release) - 20mg; 81mg - nifedipine 20mg; acetylsalicylic acid 81mg - dihydropyridines

Canada - English - Health Canada

bayer inc - nifedipine; acetylsalicylic acid - tablet (delayed-release) - 30mg; 81mg - nifedipine 30mg; acetylsalicylic acid 81mg - dihydropyridines